Prognostic factors for pancreatic neuroendocrine tumors: Analysis of 5,045 patients

被引：0
|
作者：
Bilimoria, Karl Y.
Tomlinson, James
Ko, Clifford Y.
Talamonti, Mark S.
Bentrem, David J.
机构：
来源：
GASTROENTEROLOGY | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A842 / A842
页数：1
相关论文
共 50 条
  • [1] Prognostic Factors of Survival in Patients with Pancreatic Neuroendocrine Tumors
    Popovic, B.
    Bozic, I
    Macut, D.
    Isailovic, T.
    Ognjanovic, S.
    Elezovic, V
    Petakov, M.
    Micev, M.
    Damjanovic, S.
    NEUROENDOCRINOLOGY, 2009, 90 (01) : 131 - 131
  • [2] Markers of Systemic Inflammatory Response are Prognostic Factors in Patients with Pancreatic Neuroendocrine Tumors (PNETs): A Prospective Analysis
    Apostolos Gaitanidis
    Dhaval Patel
    Naris Nilubol
    Amit Tirosh
    Samira Sadowski
    Electron Kebebew
    Annals of Surgical Oncology, 2018, 25 : 122 - 130
  • [3] Markers of Systemic Inflammatory Response are Prognostic Factors in Patients with Pancreatic Neuroendocrine Tumors (PNETs): A Prospective Analysis
    Gaitanidis, Apostolos
    Patel, Dhaval
    Nilubol, Naris
    Tirosh, Amit
    Sadowski, Samira
    Kebebew, Electron
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (01) : 122 - 130
  • [4] Markers of Systemic Inflammatory Response Are Prognostic Factors in Patients with Pancreatic Neuroendocrine Tumors (PNETs): A Prospective Analysis
    Gaitanidis, Apostolos
    Patel, Dhaval
    Nilubol, Naris
    Tirosh, Amit
    Sadowski, Samira
    Kebebew, Electron
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2017, 225 (04) : S70 - S71
  • [5] Prognostic factors and survival in 144 patients with gastro-entero-pancreatic neuroendocrine tumors
    Panzuto, F
    Nasoni, S
    Cattaruzza, MS
    Milione, M
    Cassetta, S
    Tornatore, V
    Di Fonzo, M
    Capurso, G
    Corleto, VD
    Bordi, C
    Delle Fave, G
    GASTROENTEROLOGY, 2004, 126 (04) : A391 - A392
  • [6] Streptozocin and 5-Fluorouracil for the Treatment of Pancreatic Neuroendocrine Tumors: Efficacy, Prognostic Factors and Toxicity
    Antonodimitrakis, Pantelis Clewemar
    Sundin, Anders
    Wassberg, Cecilia
    Granberg, Dan
    Skogseid, Britt
    Eriksson, Barbro
    NEUROENDOCRINOLOGY, 2016, 103 (3-4) : 345 - 353
  • [7] Streptozocin and 5-fluorouracil treatment of pancreatic neuroendocrine tumors: efficacy, toxicity and prognostic factors
    Eriksson, B.
    Sundin, A.
    Wassberg, C.
    Skogseid, B.
    Antonodimitrakis, P.
    WIENER KLINISCHE WOCHENSCHRIFT, 2014, 126 : S145 - S145
  • [8] Prognostic biomarkers in pancreatic neuroendocrine tumors
    Heaphy, Christopher M.
    VandenBussche, Christopher J.
    CANCER CYTOPATHOLOGY, 2021, 129 (11) : 841 - 843
  • [9] RETRACTED: Pancreatic neuroendocrine tumors. Prognostic factors (Retracted Article)
    Cienfuegos, Javier A.
    Rotellar, Fernando
    Ruiz-Canela, Miguel
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2017, 109 (10) : 738 - 738
  • [10] Prognostic factors and survival in patients with neuroendocrine tumors of the pancreas
    Wang, De-shen
    Zhang, Dong-sheng
    Qiu, Miao-zhen
    Wang, Zhi-qiang
    Luo, Hui-yan
    Wang, Feng-hua
    Li, Yu-hong
    Xu, Rui-hua
    TUMOR BIOLOGY, 2011, 32 (04) : 697 - 705
12345